Catalyst Wire Dossier Catalyst Wire Dossier

IGFBP-2 vaccine

IGFBP-2 vaccine · University of Washington
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IGFBP-2 vaccine, covering 2022-01-14 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence [Phase 2]

See pricing